PADAGIS ISRAEL Company Profile
✉ Email this page to a colleague
What is the competitive landscape for PADAGIS ISRAEL, and what generic and branded alternatives to PADAGIS ISRAEL drugs are available?
PADAGIS ISRAEL has seventy-seven approved drugs.
Summary for PADAGIS ISRAEL
US Patents: | 0 |
Tradenames: | 48 |
Ingredients: | 48 |
NDAs: | 77 |
Patent Litigation for PADAGIS ISRAEL: | See patent lawsuits for PADAGIS ISRAEL |
Drugs and US Patents for PADAGIS ISRAEL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Padagis Israel | FLUOCINONIDE | fluocinonide | CREAM;TOPICAL | 090256-001 | Jan 14, 2014 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Padagis Israel | CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | benzoyl peroxide; clindamycin phosphate | GEL;TOPICAL | 090979-001 | Jun 26, 2012 | AB | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Padagis Israel | IVERMECTIN | ivermectin | CREAM;TOPICAL | 210225-001 | Apr 13, 2020 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for PADAGIS ISRAEL drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Vaginal Cream | 2% | ➤ Subscribe | 2009-12-23 |
Similar Applicant Names
Here is a list of applicants with similar names.